Ticker brief
CRH
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
19
authors 14d
14
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-06-21 → 2026-06-27 · now -0.10 (−1 bearish … +1 bullish)
Who spoke14
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @akishore | C | +1.67 | 3 | +0.05 |
| @ConsensusGurus | B | +1.10 | 2 | -0.10 |
| @FintwitAi | C | -0.66 | 2 | -0.10 |
| @financespotnews | C | -0.87 | 2 | -0.10 |
| @IngJuanPa7 | B | +2.30 | 1 | -0.10 |
| @Newsquawk | B | · | 1 | -0.25 |
| @cnfinancewatch | B | -1.61 | 1 | -0.10 |
| @OpenOutcrier | C | · | 1 | -0.10 |
| @MikeZaccardi | B | -0.80 | 1 | +0.10 |
| @IBDinvestors | B | +1.52 | 1 | -0.10 |
| @SquawkStreet | C | -0.55 | 1 | -0.10 |
| @4ki4 | C | +0.57 | 1 | -0.10 |
| @FT | A | -1.68 | 1 | +0.25 |
| @RealNickMugalli | B | +1.43 | 1 | +0.30 |
Recent signals19of 19 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-06-27 | @financespotnews | -0.10 | CRH agreed to acquire Arcosa for $8.5B cash at $150/share, 25% premium. | · | tweet ↗ |
| 2026-06-22 | @RealNickMugalli | +0.30 | Session recap frames rotation out of mega-cap tech into healthcare, real assets, and AI infrastructure. | · | tweet ↗ |
| 2026-06-22 | @FT | +0.25 | Opinion frames CRH as seeking a bigger share of the US construction boom. | · | tweet ↗ |
| 2026-06-22 | @akishore | +0.35 | Asks whether CRH consolidation pace forces defensive moves and whether EXP or SUM become targets. | · | tweet ↗ |
| 2026-06-22 | @akishore | -0.10 | CRH paid 32% premium for ACA at $150/share; assets align with infrastructure and clean energy spending. | · | tweet ↗ |
| 2026-06-22 | @akishore | -0.10 | CRH is buying Arcosa for $8.5B cash, $150/share, a 32% premium. | · | tweet ↗ |
| 2026-06-22 | @4ki4 | -0.10 | Alcosa rises after agreeing to be acquired by CRH for $8.5B; both stock moves cited. | · | tweet ↗ |
| 2026-06-22 | @financespotnews | -0.10 | CRH agreed to acquire ACA for $8.5B cash at $150/share. | · | tweet ↗ |
| 2026-06-22 | @SquawkStreet | -0.10 | CRH CEO discusses the company's plan to acquire ACA for $8.5B. | · | tweet ↗ |
| 2026-06-22 | @FintwitAi | -0.10 | Reports CRH acquired Arcosa in an $8.5B all-cash deal. | · | tweet ↗ |
| 2026-06-22 | @IBDinvestors | -0.10 | CRH reportedly buys a major GE Vernova supplier for $8.5B. | · | tweet ↗ |
| 2026-06-22 | @FintwitAi | -0.10 | Reports CRH acquiring a major GE Vernova supplier for $8.5B. | · | tweet ↗ |
| 2026-06-22 | @MikeZaccardi | +0.10 | Mentions CRH and ABBV in a Merger Monday context without transaction details. | · | tweet ↗ |
| 2026-06-22 | @OpenOutcrier | -0.10 | CRH to buy Arcosa in $8.5B all-cash deal at $150 per share. | · | tweet ↗ |
| 2026-06-22 | @cnfinancewatch | -0.10 | News roundup includes announced acquisitions of APGE by ABBV and ACA by CRH with deal values and premium. | · | tweet ↗ |
| 2026-06-22 | @Newsquawk | -0.25 | Pre-market movers list price moves and company-specific events across several stocks. | · | tweet ↗ |
| 2026-06-22 | @IngJuanPa7 | -0.10 | CRH announced all-cash acquisition of Arcosa for about $8.5B at $150/share, 10.4% premium. | · | tweet ↗ |
| 2026-06-22 | @ConsensusGurus | -0.10 | Reports CRH buying Arcosa for $150/share and AbbVie buying Apogee for $135.11/share cash. | · | tweet ↗ |
| 2026-06-21 | @ConsensusGurus | -0.10 | FT reports CRH nears biggest-ever deal to buy Arcosa; author notes timing feels off. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.